Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Immunodeficiency Virus-Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02376582
What this trial is testing

Safety and Immunogenicity Study of a DNA Vaccine Combined With Protein Vaccine Against HIV/AIDS

Who this might be right for
HIV/AIDS
EuroVacc Foundation 72
Not applicableStudy completedNCT03772327
What this trial is testing

HIV Adherence Bottle Intervention Trial

Who this might be right for
HIV-1-infectionAdherence, Medication
Weill Medical College of Cornell University 63
Not applicableUnknownNCT03597243
What this trial is testing

Cash Transfer to Adolescent Girls and Young Women to Reduce Sexual Risk Behavior - an Impact Evaluation

Who this might be right for
HIV/AIDSHSV-2 Infection
National Institute for Medical Research, Tanzania 3,120
Not applicableLooking for participantsNCT07293559
What this trial is testing

Understanding Practices of Lactation and Infant Feeding Together With Women With HIV in the United States

Who this might be right for
HIV-1-infectionBreastfeedingPregnancy Related
International Maternal Pediatric Adolescent AIDS Clinical Trials Group 1,150
Testing effectiveness (Phase 2)Looking for participantsNCT07336797
What this trial is testing

Effect of Empagliflozin on Metabolic Outcomes in Adults Living With HIV Receiving Dolutegravir-Based Therapy

Who this might be right for
Metabolic SyndromeObesity & OverweightHIV (Human Immunodeficiency Virus)
Abdelrahman Mahmoud 66
Not applicableStudy completedNCT01869010
What this trial is testing

Severe Impairment of Solute-Free Water Clearance in Patients With HIV Infection

Who this might be right for
HIV Infection
Hospital Italiano de Buenos Aires 30
Not applicableEnded earlyNCT04024488
What this trial is testing

Group-Based Intervention to Improve Mental Health and Adherence Among Youth Living With HIV in Low Resource Settings

Who this might be right for
HIV-1-infection
International Maternal Pediatric Adolescent AIDS Clinical Trials Group 484
Not applicableStudy completedNCT01159743
What this trial is testing

A Comparison of Body Fat Distribution in HIV-1 Infected Patients Receiving, Since the Beginning and for at Least Two Years, an Antiretroviral Therapy Based on Efavirenz or Lopinavir/Ritonavir Combined With Tenofovir + Emtricitabine or Lamivudine

Who this might be right for
HIV Infection
AbbVie (prior sponsor, Abbott) 346
Testing effectiveness (Phase 2)Study completedNCT03091374
What this trial is testing

Impact of Recombinant Human Growth Hormone on HIV Persistence

Who this might be right for
Human Immunodeficiency VirusGrowth Hormone Treatment
McGill University Health Centre/Research Institute of the McGill University Health Centre 22
Not applicableStudy completedNCT01331460
What this trial is testing

HIV and Drug Use in Georgian Women

Who this might be right for
Human Immunodeficiency Virus
University of North Carolina, Chapel Hill 128
Testing effectiveness (Phase 2)Study completedNCT00126880
What this trial is testing

AVX754 (a New Nucleoside Reverse Transcriptase Inhibitor [NRTI]) to Treat Drug-resistant HIV

Who this might be right for
HIV Infections
Avexa 52
Not applicableStudy completedNCT00037076
What this trial is testing

Prevalence of Hepatitis C Virus Infection in HIV-Infected Children

Who this might be right for
HIV InfectionsHepatitis C
National Institute of Allergy and Infectious Diseases (NIAID) 600
Large-scale testing (Phase 3)Study completedNCT04597424
What this trial is testing

Combined Prevention of Sexually Transmitted Infections (STIs) in Men Who Have Sex With Men and Using Oral Tenofovir Disoproxil Fumarate/ Emtricitabine (TDF/FTC) for HIV Pre-Exposure Prophylaxis (PrEP)

Who this might be right for
Unsafe SexRisk-Taking
ANRS, Emerging Infectious Diseases 556
Not applicableStudy completedNCT00000947
What this trial is testing

Evaluate the Effects of Azithromycin on MAC Disease Prevention in HIV-Positive Patients

Who this might be right for
Mycobacterium Avium-intracellulare InfectionHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 850
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07510048
What this trial is testing

Combatting HIV Or Other STIs Early (CHOOSE)

Who this might be right for
HIVSTIsSTIs Prevention+1 more
Westat 200
Early research (Phase 1)Ended earlyNCT00757250
What this trial is testing

Safety Study of TXA127 to Elevate CD4+ T-Lymphocyte Counts in HIV-Infected Patients on Stable HAART Therapy

Who this might be right for
HIV Infections
US Biotest, Inc. 13
Testing effectiveness (Phase 2)Study completedNCT00145249
What this trial is testing

Amphotericin Alone or in Combination With Fluconazole for AIDS-Associated Meningitis

Who this might be right for
Cryptococcal Meningitis
National Institute of Allergy and Infectious Diseases (NIAID) 143
Not applicableStudy completedNCT03584048
What this trial is testing

Charlotte Retention in Care Study

Who this might be right for
HIV I Infection
Epividian 6,500
Not applicableStudy completedNCT03069235
What this trial is testing

Promoting Exclusive Breastfeeding Among HIV Infected Women in a PMTCT Program

Who this might be right for
HIV-infection/AidsBreast Feeding
Johns Hopkins University 218
Large-scale testing (Phase 3)Study completedNCT00524368
What this trial is testing

Compare Effectiveness and Safety of Darunavir/Ritonavir (DRV/Rtv) 800mg/100mg Once Daily Versus DRV/Rtv 600mg/100mg Twice Daily in Early Treatment-Experienced HIV-1 Infected Patients (ODIN)

Who this might be right for
Human Immunodeficiency Virus - Type 1
Tibotec Pharmaceuticals, Ireland 590
Next Page